MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, J.
Right arrow Articles by Barnard, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, J.
Right arrow Articles by Barnard, E. A.

0026-895X/97/020237-12$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:237-248 (1997).

Localization and Functional Expression of Splice Variants of the P2X2 Receptor

Joseph Simon, Emma J. Kidd, Fiona M. Smith, Iain P. Chessell, Ruth Murrell-Lagnado, Patrick P. A. Humphrey, and Eric A. Barnard

Molecular Neurobiology Unit, Royal Free Hospital School of Medicine, London, NW3 2PF, United Kingdom (J.S., E.A.B.), and Glaxo Institute of Applied Pharmacology (J.S., E.J.K., F.M.S., I.P.C., P.P.A.H.) and Department of Pharmacology (F.M.S., R.M.-L.), University of Cambridge, Cambridge CB2 1QJ, United Kingdom

cDNAs encoding three splice variants of the P2X2 receptor were isolated from rat cerebellum. The first variant has a serine/proline-rich segment deleted from the intracellularly located carboxyl-terminal domain of the P2X2 subunit. The second and third variants have the splice site in the second half of the predicted first transmembrane domain. Either a 12-amino acid insertion or a six-amino acid deletion occurs at this position. cRNAs for these isoforms of the P2X2 subunit were injected into Xenopus laevis oocytes and tested for function. ATP evoked inward currents only with the splice variant [designated P2X2(b)] having the 69-amino acid deletion. The potencies of various agonists at the homomeric P2X2(b) receptor were not significantly different from those at the P2X2(a) homomeric channel. However, the P2X2(b) receptor showed significantly lower antagonist sensitivity. In contrast to the nondesensitizing P2X2(a) receptor, prolonged application of ATP produced a more rapid desensitization of the P2X2(b) receptor. When the P2X2(a) and P2X2(b) receptor responses were recorded in transfected mammalian cells, this difference was again found. The change in desensitization may be determined by proline/serine-rich segments and/or phosphorylation motifs that are removed from the tail region in formation of the P2X2(b) subunit. In situ hybridization of the three newly isolated isoforms of the P2X2 subunit was performed at the macroscopic and cellular levels; transcripts for two of them [P2X2(b) and p2x2(c)] but not the third [p2x2(d)], which carries the 12-amino acid addition, were present in many structures in the neonatal rat brain and on sensory and sympathetic ganglia. mRNA for the p2x2(d) splice variant was present only in the nodose ganglion, at a low level.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. K. Tittle and R. I. Hume
Opposite Effects of Zinc on Human and Rat P2X2 Receptors
J. Neurosci., October 29, 2008; 28(44): 11131 - 11140.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. L. da Silva, R. R. Resende, and H. Ulrich
Genomic Physiology: Alternative splicing of P2X6 receptors in developing mouse brain and during in vitro neuronal differentiation
Exp Physiol, January 1, 2007; 92(1): 139 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. A. Campanucci, M. Zhang, C. Vollmer, and C. A. Nurse
Expression of Multiple P2X Receptors by Glossopharyngeal Neurons Projecting to Rat Carotid Body O2-Chemoreceptors: Role in Nitric Oxide-Mediated Efferent Inhibition.
J. Neurosci., September 13, 2006; 26(37): 9482 - 9493.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T.-a. Koshimizu, K. Kretschmannova, M.-L. He, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Carboxyl-Terminal Splicing Enhances Physical Interactions between the Cytoplasmic Tails of Purinergic P2X Receptors
Mol. Pharmacol., May 1, 2006; 69(5): 1588 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Masin, D. Kerschensteiner, K. Dumke, M. E. Rubio, and F. Soto
Fe65 Interacts with P2X2 Subunits at Excitatory Synapses and Modulates Receptor Function
J. Biol. Chem., February 17, 2006; 281(7): 4100 - 4108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Ohta, A. Kubota, M. Murakami, K.-i. Otsuguro, and S. Ito
P2X2 receptors are essential for [Ca2+]i increases in response to ATP in cultured rat myenteric neurons
Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G935 - G948.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Zemkova, M.-L. He, T.-a. Koshimizu, and S. S. Stojilkovic
Identification of Ectodomain Regions Contributing to Gating, Deactivation, and Resensitization of Purinergic P2X Receptors
J. Neurosci., August 4, 2004; 24(31): 6968 - 6978.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Calvert and R. J. Evans
Heterogeneity of P2X Receptors in Sympathetic Neurons: Contribution of Neuronal P2X1 Receptors Revealed Using Knockout Mice
Mol. Pharmacol., January 1, 2004; 65(1): 139 - 148.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. He, H. Zemkova, and S. S. Stojilkovic
Dependence of Purinergic P2X Receptor Activity on Ectodomain Structure
J. Biol. Chem., March 14, 2003; 278(12): 10182 - 10188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto
Heteromultimerization Modulates P2X Receptor Functions through Participating Extracellular and C-terminal Subdomains
J. Biol. Chem., November 27, 2002; 277(49): 46891 - 46899.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M.-L. He, T.-a. Koshimizu, M. Tomic', and S. S. Stojilkovic
Purinergic P2X2 Receptor Desensitization Depends on Coupling between Ectodomain and C-Terminal Domain
Mol. Pharmacol., November 1, 2002; 62(5): 1187 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. North
Molecular Physiology of P2X Receptors
Physiol Rev, October 1, 2002; 82(4): 1013 - 1067.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
A. N. Eickhorst, A. Berson, D. Cockayne, H. A. Lester, and B. S. Khakh
Control of P2X2 Channel Permeability by the Cytosolic Domain
J. Gen. Physiol., July 30, 2002; 120(2): 119 - 131.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Ennion and R. J. Evans
Conserved Cysteine Residues in the Extracellular Loop of the Human P2X1 Receptor Form Disulfide Bonds and Are Involved in Receptor Trafficking to the Cell Surface
Mol. Pharmacol., February 1, 2002; 61(2): 303 - 311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. W. Inscho
P2 receptors in regulation of renal microvascular function
Am J Physiol Renal Physiol, June 1, 2001; 280(6): F927 - F944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. M. White, J. D. Imig, T.-T. Kim, B. C. Hauschild, and E. W. Inscho
Calcium signaling pathways utilized by P2X receptors in freshly isolated preglomerular MVSMC
Am J Physiol Renal Physiol, June 1, 2001; 280(6): F1054 - F1061.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Drutel, N. Peitsaro, K. Karlstedt, K. Wieland, M. J. Smit, H. Timmerman, P. Panula, and R. Leurs
Identification of Rat H3 Receptor Isoforms with Different Brain Expression and Signaling Properties
Mol. Pharmacol., January 1, 2001; 59(1): 1 - 8.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T.-a. Koshimizu, M. Tomic, A. O.-L. Wong, D. Zivadinovic, and S. S. Stojilkovic
Characterization of Purinergic Receptors and Receptor-Channels Expressed in Anterior Pituitary Cells
Endocrinology, November 1, 2000; 141(11): 4091 - 4099.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Chen, M. S. Parker, A. P. Barnes, P. Deininger, and R. P. Bobbin
Functional Expression of Three P2X2 Receptor Splice Variants From Guinea Pig Cochlea
J Neurophysiol, March 1, 2000; 83(3): 1502 - 1509.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Zhong, P. M Dunn, and G. Burnstock
Guinea-pig sympathetic neurons express varying proportions of two distinct P2X receptors
J. Physiol., March 1, 2000; 523(2): 391 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, M. Koshimizu, and S. S. Stojilkovic
Contributions of the C-terminal Domain to the Control of P2X Receptor Desensitization
J. Biol. Chem., December 31, 1999; 274(53): 37651 - 37657.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. J. Lynch, E. Touma, W. Niforatos, K. L. Kage, E. C. Burgard, T. van Biesen, E. A. Kowaluk, and M. F. Jarvis
Molecular and Functional Characterization of Human P2X2 Receptors
Mol. Pharmacol., December 1, 1999; 56(6): 1171 - 1181.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
G. D. Housley, R. Kanjhan, N. P. Raybould, D. Greenwood, S. G. Salih, L. Jarlebark, L. D. Burton, V. C. M. Setz, M. B. Cannell, C. Soeller, et al.
Expression of the P2X2 Receptor Subunit of the ATP-Gated Ion Channel in the Cochlea: Implications for Sound Transduction and Auditory Neurotransmission
J. Neurosci., October 1, 1999; 19(19): 8377 - 8388.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. M Smith, P. P A Humphrey, and R. D Murrell-Lagnado
Identification of amino acids within the P2X2 receptor C-terminus that regulate desensitization
J. Physiol., October 1, 1999; 520(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T.-a. Koshimizu, M. Tomic, F. Van Goor, and S. S. Stojilkovic
Functional Role of Alternative Splicing in Pituitary P2X2 Receptor-Channel Activation and Desensitization
Mol. Endocrinol., July 1, 1998; 12(7): 901 - 913.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T.-a. Koshimizu, M. Tomic, M. Koshimizu, and S. S. Stojilkovic
Identification of Amino Acid Residues Contributing to Desensitization of the P2X2 Receptor Channel
J. Biol. Chem., May 22, 1998; 273(21): 12853 - 12857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ennion, S. Hagan, and R. J. Evans
The Role of Positively Charged Amino Acids in ATP Recognition by Human P2X1 Receptors
J. Biol. Chem., September 15, 2000; 275(38): 29361 - 29367.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics